Tech Company Financing Transactions
Rani Therapeutics Funding Round
Samsara Ventures, Avenue Capital and private investors joined a $60.3 million venture round for Rani Therapeutics. The round was announced on 10/23/2025.
Transaction Overview
Company Name
Announced On
10/23/2025
Transaction Type
Venture Equity
Amount
$60,300,000
Round
Undisclosed
Investors
Samsara Ventures (Lead Investor)
private investors (Mir Imran)
Proceeds Purpose
The Company intends to use the net proceeds from the private placement to support the continued advancement of the Company's pipeline using the RaniPill® platform.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
2051 Ringwood Ave.
San Jose, CA 95131
USA
San Jose, CA 95131
USA
Phone
Website
Email Address
Overview
Rani Therapeutics is developing a novel approach for the oral delivery of large drug molecules, which to date can only be delivered through injections.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mir Imran
Chief Financial Officer
Svai Sanford
Chief Scientific Officer
Mir Hashim
Vice President
Angela Murch
Vice President
Maulik Nanavaty
VP - Bus. Development
Talat Imran
VP - Bus. Development
Stephanie McGrory
VP - Engineering
Mohsen Shirazi
VP - Regulatory Affairs
Arvinder Dhalla
VP - Regulatory Affairs
Betsy Gutierrez
Browse more venture capital transactions:
Prev: 10/23/2025: WSense venture capital transaction
Next: 10/23/2025: Wolf Games venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs